<DOC>
	<DOCNO>NCT00941824</DOCNO>
	<brief_summary>Mycophenolate acid ( MPA ) develop approve combination cyclosporine use kidney transplantation decade . At present , combination tacrolimus mycophenolate acid tend consider standard care maintenance immunosuppression kidney transplantation . Mainly due different effect entero-hepatic recycle pathway , cyclosporine tacrolimus differently interfere MPA clearance . When used tacrolimus , MPA dosage thus adjust extrapolate recommended cyclosporine-based treatment . However , currently clear guideline MPA dose drug use combination tacrolimus . This potentially detrimental patient since under-or overexposure MPA clinically link outcome transplantation . The purpose study pharmacologically validate original MPA dose regimen combination tacrolimus within three month post-kidney transplant . This regimen consist intensified dose mycophenolate sodium early period transplantation order rapidly reach appropriate MPA blood exposure follow gradual decrease dose order prevent MPA overexposure .</brief_summary>
	<brief_title>Pharmacokinetic Evaluation Intensified Decreasing Dosing Regimen Mycophenolate Sodium Combination With Tacrolimus Post Kidney Transplant : The Myfortic Study</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>&gt; 18 year Renal transplant dead alive donor . Patients treat initial quadritherapy basiliximab , tacrolimus , steroid et mycophenolate sodic ΒHCG pregnancy test negative initiation Myfortic ® Effective contraception treatment 6 week treatment Myfortic ® Patient high risk rejection transplant IMC &gt; ou = 30 Platelets &lt; 75000 / mm3 and/or neutrophil &lt; 1500 / mm3 and/or leukocytes &lt; 2500/ mm3 and/or hemoglobin &lt; 6 g/dL . Patient require antiCMV prophylaxis valganciclovir . Pregnancy breast feeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>pharmacokinetic</keyword>
	<keyword>mycophénolate acid</keyword>
	<keyword>kidney transplantation</keyword>
</DOC>